← Back to Patent Explorer
US4900546A Expired / Lapsed US ⏱️ 0.0 years remaining

Bone cement for sustained release of substances

Assignee: Howmedica Osteonics Corp
•
Filing: 1987-07-30
•
Granted: 1990-02-13
•
Expires: 2007-07-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A bone cement is disclosed wherein the liquid component contains a therapeutic or diagnostic substance in combination with an emulsifying agent for said substance.

Inventors

  • 👤 Jessica D. Posey-Dowty
  • 👤 Paul A. Higham
  • 👤 Nestor Arroyo
  • 👤 Casper F. Stark

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:05
CPC Classifications
A; A61; A61L; A61L24/00; A61L24/001; A61L24/0015; A61L24/04; A61L24/06; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/406; A61L2430/00; A61L2430/02

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 69 words
A bone cement composition comprising the combination of components A and B wherein: Component A comprises a powdered polymer or copolymer of an acrylic ester and, component B comprises a liquid monomer of an acrylic ester containing (a) erythromycin or pharmaceutically acceptable salts thereof, an emulsifying agent for erythromycin, or pharmaceutically acceptable salts thereof, whereby the incorporation of erythromycin, or pharmaceutically acceptable salts thereof, is substantially in component B.
Claim 2
Dependent Claim 69 words
A bone cement composition comprising the combination of components A and B wherein: Component A comprises a powdered polymer or copolymer of an acrylic ester and, component B comprises a liquid monomer of an acrylic ester containing (a) erythromycin or pharmaceutically acceptable salts thereof, an emulsifying agent for erythromycin, or pharmaceutically acceptable salts thereof, whereby the incorporation of erythromycin, or pharmaceutically acceptable salts thereof, is substantially in component B.
Claim 3
Dependent Claim 12 words
The bone cement of claim 1 wherein component A is polymethyl methacrylate.
Claim 4
Dependent Claim 16 words
The bone cement of claim 1 wherein component A is a copolymer of methylmethacrylate and styrene.
Claim 5
Dependent Claim 11 words
The bone cement of claim 1 wherein component B is methylmethacrylate.
Claim 6
Dependent Claim 14 words
The bone cement of claim 1 wherein said emulsifying agent is sorbitan mono-oleate polyoxyethylene.
Claim 7
Dependent Claim 14 words
The bone cement of claim 7 wherein said emulsifying agent is sodium dihexyl sulfosuccinate.
Claim 8
Dependent Claim 27 words
A liquid monomer of an acrylic ester containing (a) erythromycin, or pharmaceutically acceptable salts thereof and (b) an emulsifying agent for erythromycin, or pharmaceutically acceptable salts thereof.
Claim 9
Dependent Claim 27 words
A liquid monomer of an acrylic ester containing (a) erythromycin, or pharmaceutically acceptable salts thereof and (b) an emulsifying agent for erythromycin, or pharmaceutically acceptable salts thereof.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-02-12 1993-08-14 1994-02-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-02-12 1997-08-14 1998-02-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-02-12 2001-08-14 2002-02-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag